The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement
Open accessAbstract
Background and Aims: Electronic health record (EHR)‐based research allows the capture of large amounts of data, which is necessary in NAFLD, where the risk of clinical liver outcomes is generally low. The lack of consensus on which International Classification of Diseases (ICD) codes should be used as exposures and outcomes limits comparability and generalizability of results across studies. We aimed to establish consensus among a panel of experts on ICD codes that could become the reference standard and provide guidance around common methodological issues. Approach and Results: Researchers with an interest in EHR‐based NAFLD research were invited to collectively define which administrative codes are most appropriate for documenting exposures and outcomes. We used a modified Delphi approach to reach consensus on several commonly encountered methodological challenges in the field. After two rounds of revision, a high level of agreement (>67%) was reached on all items considered. Full consensus was achieved on a comprehensive list of administrative codes to be considered for inclusion and exclusion criteria in defining exposures and outcomes in EHR‐based NAFLD research. We also provide suggestions on how to approach commonly encountered methodological issues and identify areas for future research. Conclusions: This expert panel consensus statement can help harmonize and improve generalizability of EHR‐based NAFLD research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Diamond, I. R., Grant, R. C., Feldman, B. M., Pencharz, P. B., Ling, S. C., Moore, A. M., & Wales, P. W. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.12.002 · Cited by 3,740
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287
Self-citationConsensus development methods, and their use in clinical guideline development.
Murphy, Black, Lamping, McKee, Sanderson, Askham, & Marteau (1998) · Health Technology Assessment · doi:10.3310/hta2030 · Cited by 2,051
Hagström, H., Nasr, P., Ekstedt, M., Hammar, U., Stål, P., Hultcrantz, R., & Kechagias, S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.027 · Cited by 1,067
Self-citationRisk of hepatocellular cancer in patients with non-alcoholic fatty liver disease
Kanwal, F., Kramer, J. R., Mapakshi, S., Natarajan, Y., Chayanupatkul, M., Richardson, P. A., Li, L., Desiderio, R., Thrift, A. P., Asch, S. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.024 · Cited by 795
Self-citationFeldstein, A. E., Charatcharoenwitthaya, P., Treeprasertsuk, S., Benson, J. T., Enders, F. B., & Angulo, P. (2009) · Gut · doi:10.1136/gut.2008.171280 · Cited by 726
Allen, A. M., Therneau, T. M., Larson, J. J., Coward, A., Somers, V. K., & Kamath, P. S. (2018) · Hepatology · doi:10.1002/hep.29546 · Cited by 370
Self-citationAlexander, M., Loomis, A. K., van der Lei, J., Duarte-Salles, T., Prieto-Alhambra, D., Ansell, D., Pasqua, A., Lapi, F., Rijnbeek, P., Mosseveld, M., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1321-x · Cited by 317
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease
Alexander, M., Loomis, A. K., Fairburn-Beech, J., van der Lei, J., Duarte-Salles, T., Prieto-Alhambra, D., Ansell, D., Pasqua, A., Lapi, F., Rijnbeek, P., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1103-x · Cited by 272
Alexander, M., Loomis, A. K., van der Lei, J., Duarte-Salles, T., Prieto-Alhambra, D., Ansell, D., Pasqua, A., Lapi, F., Rijnbeek, P., Mosseveld, M., et al. (2019) · BMJ · doi:10.1136/bmj.l5367 · Cited by 254
Beyond randomized controlled trials: A critical comparison of trials with nonrandomized studies
Sφrensen, H. T., Lash, T. L., & Rothman, K. J. (2006) · Hepatology · doi:10.1002/hep.21404 · Cited by 236
Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study
Liu, B., Balkwill, A., Reeves, G., Beral, V., & Collaborators., O. B. O. T. M. W. S. (2010) · BMJ · doi:10.1136/bmj.c912 · Cited by 202
Hagström, H., Talbäck, M., Andreasson, A., Walldius, G., & Hammar, N. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.09.008 · Cited by 182
Self-citationRisks of light and moderate alcohol use in fatty liver disease: follow-up of population cohorts
Åberg, F., Puukka, P., Salomaa, V., Männistö, S., Lundqvist, A., Valsta, L., Perola, M., Färkkilä, M., & Jula, A. (2020) · Hepatology · doi:10.1002/hep.30864 · Cited by 176
Self-citationAllen, A. M., Van Houten, H. K., Sangaralingham, L. R., Talwalkar, J. A., & McCoy, R. G. (2018) · Hepatology · doi:10.1002/hep.30094 · Cited by 158
Self-citationRe, V. L., Lim, J. K., Goetz, M. B., Tate, J., Bathulapalli, H., Klein, M. B., Rimland, D., Rodriguez‐Barradas, M. C., Butt, A. A., Gibert, C. L., et al. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2148 · Cited by 156
Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen, P., Vilstrup, H., Mellemkjær, L., Thulstrup, A. M., Olsen, J. H., Baron, J. A., & Sørensen, H. T. (2003) · PubMed · Cited by 152
Self-citationGoldberg, D. S., Lewis, J. S., Halpern, S. D., Weiner, M. G., & Re, V. L. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3290 · Cited by 150
Wild, S. H., Walker, J. J., Morling, J. R., McAllister, D., Colhoun, H. M., Farran, B., McGurnaghan, S. J., McCrimmon, R. J., Read, S. H., Sattar, N. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1590 · Cited by 143
Self-citationLapointe‐Shaw, L., Georgie, F., Carlone, D., Cerocchi, O., Chung, H., DeWit, Y., Feld, J. J., Holder, L., Kwong, J. C., Sander, B., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201120 · Cited by 143
Nonalcoholic Fatty Liver Disease is Underrecognized in the Primary Care Setting
Blais, P., Husain, N. S., Kramer, J. R., Kowalkowski, M. A., El‐Serag, H. B., & Kanwal, F. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.134 · Cited by 140
Self-citationKaplan, D. E., Dai, F., Aytaman, A., Baytarian, M., Fox, R., Hunt, K., Knott, A., Pedrosa, M., Pocha, C., Mehta, R., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.010 · Cited by 139
Ünalp–Arida, A., & Ruhl, C. E. (2019) · Hepatology · doi:10.1002/hep.31032 · Cited by 123
Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis
Bengtsson, B., Stal, P. I., Wåhlin, S., Björkström, N. K., & Hagström, H. (2019) · Liver International · doi:10.1111/liv.14087 · Cited by 112
Self-citationHagström, H., Tynelius, P., & Rasmussen, F. E. (2017) · Gut · doi:10.1136/gutjnl-2016-313622 · Cited by 98
Self-citationValidity of administrative codes associated with cirrhosis in Sweden
Bengtsson, B., Askling, J., Ludvigsson, J. F., & Hagström, H. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2020.1820566 · Cited by 92
Self-citationCorey, K. E., Kartoun, U., Zheng, H., & Shaw, S. Y. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3952-x · Cited by 88
Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions
Åberg, F. O., & Färkkilä, M. A. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1701443 · Cited by 88
Self-citationNon‐alcoholic fatty liver disease increases the risk of incident chronic kidney disease
Kaps, L., Labenz, C., Galle, P. R., Weinmann‐Menke, J., Kostev, K., & Schattenberg, J. M. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620944098 · Cited by 59
Self-citationIdentifying Patients With Hepatic Encephalopathy Using Administrative Data in the ICD-10 Era
Tapper, E. B., Korovaichuk, S., Baki, J., Williams, S., Nikirk, S. J., Waljee, A. K., & Parikh, N. D. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.12.017 · Cited by 55
Self-citationHusain, N. S., Blais, P., Kramer, J. R., Kowalkowski, M. A., Richardson, P., El‐Serag, H. B., & Kanwal, F. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12923 · Cited by 45
Self-citationDriver, R. J., Balachandrakumar, V. K., Burton, A. J., Shearer, J. E., Downing, A., Cross, T. J. S., Morris, E. J. A., & Rowe, I. A. C. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028571 · Cited by 21
Self-citation
Cited by
Advancing the global public health agenda for NAFLD: a consensus statement
Lazarus, J. V., Mark, H. E., Anstee, Q. M., Arab, J. P., Batterham, R. L., Castera, L., Cortez-Pinto, H., Crespo, J., Cusi, K., Dirac, M. A., et al. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00523-4 · Cited by 757
Self-citationKarlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652
Self-citationZhang, X., Wong, G. L., Yip, T. C., Tse, Y., Liang, L. Y., Hui, V. W., Lin, H., Li, G., Lai, J. C., Chan, H. L., et al. (2022) · Hepatology · doi:10.1002/hep.32294 · Cited by 93
Self-citationKendall, T. J., Jimenez-Ramos, M., Turner, F., Ramachandran, P., Minnier, J., McColgan, M. D., Alam, M., Ellis, H., Dunbar, D. R., Kohnen, G., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02602-2 · Cited by 92
Ebrahimi, F., Hagström, H., Sun, J., Bergman, D., Shang, Y., Yang, W., Roelstraete, B., & Ludvigsson, J. F. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.08.018 · Cited by 65
Metadata
- Authors
- Hagström, H., Adams, L. A., Allen, A. M., Byrne, C. D., Chang, Y., Grønbæk, H., Ismail, M., Jepsen, P., Kanwal, F., Kramer, J., Lazarus, J. V., Long, M. T., Loomba, R., Newsome, P. N., Rowe, I. A., Ryu, S., Schattenberg, J. M., Serper, M., Sheron, N., Simon, T. G., Tapper, E. B., Wild, S., Wong, V. W., Yilmaz, Y., Zelber‐Sagi, S., & Åberg, F.
- Venue
- Hepatology
- Published
- 2021-06-22
- Volume
- 74
- Issue
- 1
- Pages
- 474-482
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W3126086196
- Cited by
- 259
- References
- 34
- FWCI
- 31.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.